Live from the NIH registry
Studies recruiting near Columbus right now
Top 25 of 69 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Piedmont Columbus Regional - John B. Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Eli Lilly and Company
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
Smoking Cessation
Phase 3
Interventional 705 participants sought
Clinical Research Site — Columbus, Georgia (7.3 mi)
· Sponsor: Axsome Therapeutics, Inc.
A Study to Assess the Safety, Tolerability and Efficacy of ION775
Hypertriglyceridemia, Severe Hypertriglyceridemia
Phase 2
Interventional 72 participants sought
Ionis Investigative Site — Columbus, Georgia (7.3 mi)
· Sponsor: Ionis Pharmaceuticals, Inc.
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
John B Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)
Endometriosis
N/A
Observational 1,200 participants sought
Midtown OBGYN North — Columbus, Georgia (7.3 mi)
· Sponsor: Aspira Women's Health
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Centricity Research - Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: vTv Therapeutics
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Kidney Disease
Phase 3
Interventional 347 participants sought
DCR Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: Takeda
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 661 participants sought
John B Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Bristol-Myers Squibb
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Obesity, Overweight
Phase 3
Interventional 3,600 participants sought
ACCOMPLISH-1 Research Site — Columbus, Georgia (7.3 mi)
· Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Chronic Inducible Urticaria, Cold Urticaria
Phase 3
Interventional 240 participants sought
Centricity Research Columbus Dermatology — Columbus, Georgia (7.3 mi)
· Sponsor: Celldex Therapeutics
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
Locally Advanced Pancreatic Cancer
Phase 3
Interventional 190 participants sought
Piedmont-Columbus Regional - John B. Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: RenovoRx
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast Cancer, Early Breast Cancer
Phase 3
Interventional 5,500 participants sought
Research Site — Columbus, Georgia (7.3 mi)
· Sponsor: AstraZeneca
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
IACT Health-Brookstone Centre Pkwy — Columbus, Georgia (7.3 mi)
· Sponsor: Sparrow Pharmaceuticals
A Study to Assess Growth in Children With Idiopathic Short Stature
Idiopathic Short Stature
N/A
Observational 300 participants sought
Centricity Research — Columbus, Georgia (7.3 mi)
· Sponsor: BioMarin Pharmaceutical
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Alzheimers Disease
Phase 3
Interventional 800 participants sought
Alzheimer's Research and Treatment Center - Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: Hoffmann-La Roche
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
Phase 3
Interventional 6,950 participants sought
Research Site — Columbus, Georgia (7.3 mi)
· Sponsor: AstraZeneca
Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
Lipoprotein Disorder
Phase 2
Interventional 204 participants sought
Centricity Research - Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: Kylonova (Xiamen) Biopharma co., LTD.
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Obesity, Overweight
Phase 3
Interventional 1,100 participants sought
ACCOMPLISH-2 Research Site — Columbus, Georgia (7.3 mi)
· Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
An Internet-based Program to Help Cancer Survivors Manage Pain
Cancer
N/A
Interventional 456 participants sought
John B. Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Wake Forest University Health Sciences
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
Diabetic Foot Ulcer, Foot Ulcer
Phase 3
Interventional 230 participants sought
IACT Health — Columbus, Georgia (7.3 mi)
· Sponsor: Energenesis Biomedical Co., Ltd.
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Advanced Non-small Cell Lung Cancer, HER2 Mutation
Phase 3
Interventional 444 participants sought
John B. Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Bayer
Study of GS-0415 and How It Works in People With HIV
HIV -1 Infection
Phase 1
Interventional 112 participants sought
Centricity Research CPU - Georgia — Columbus, Georgia (7.3 mi)
· Sponsor: Gilead Sciences
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Columbus, Georgia (7.3 mi)
· Sponsor: Akero Therapeutics, Inc
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Type 1 Diabetes Mellitus
Phase 3
Interventional 723 participants sought
IACT Health - Columbus - Talbotton Road- Site Number : 8400003 — Columbus, Georgia (7.3 mi)
· Sponsor: Sanofi
AETOS Shoulder System
Shoulder Osteoarthritis, Shoulder Arthritis
N/A
Observational 220 participants sought
Hughston Foundation — Columbus, Georgia (7.3 mi)
· Sponsor: Smith & Nephew, Inc.